uniQure NV (QURE)
4.535
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
4.535
0.00 (0.00%)
After-Hours: 20:00
uniQure Total Assets (Quarterly): 831.69M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 831.69M |
September 30, 2023 | 871.55M |
June 30, 2023 | 942.77M |
March 31, 2023 | 631.00M |
December 31, 2022 | 704.96M |
September 30, 2022 | 638.23M |
June 30, 2022 | 701.21M |
March 31, 2022 | 757.15M |
December 31, 2021 | 809.18M |
September 30, 2021 | 774.62M |
June 30, 2021 | 784.26M |
March 31, 2021 | 363.85M |
December 31, 2020 | 340.40M |
September 30, 2020 | 350.51M |
June 30, 2020 | 385.34M |
March 31, 2020 | 414.24M |
December 31, 2019 | 448.63M |
September 30, 2019 | 471.59M |
June 30, 2019 | 253.08M |
March 31, 2019 | 268.99M |
December 31, 2018 | 273.91M |
September 30, 2018 | 281.06M |
Date | Value |
---|---|
June 30, 2018 | 308.54M |
March 31, 2018 | 192.24M |
December 31, 2017 | 209.64M |
September 30, 2017 | 138.99M |
June 30, 2017 | 157.96M |
March 31, 2017 | 169.64M |
December 31, 2016 | 190.26M |
September 30, 2016 | 213.99M |
June 30, 2016 | 231.17M |
March 31, 2016 | 252.60M |
December 31, 2015 | 262.66M |
September 30, 2015 | 286.53M |
June 30, 2015 | 258.46M |
March 31, 2015 | 97.60M |
December 31, 2014 | 116.48M |
September 30, 2014 | 128.58M |
June 30, 2014 | 138.78M |
March 31, 2014 | 138.90M |
December 31, 2013 | 53.81M |
September 30, 2013 | 58.93M |
December 31, 2012 | 7.362M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
253.08M
Minimum
Jun 2019
942.77M
Maximum
Jun 2023
603.91M
Average
638.23M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
ProQR Therapeutics NV | 152.42M |
Merus NV | 455.49M |
argenx SE | 4.542B |
Pharming Group | 462.85M |
Pharvaris NV | 440.72M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 624.02M |
Shareholders Equity (Quarterly) | 207.67M |
Debt to Equity Ratio | 0.49 |
Current Ratio | 8.848 |
Net Debt Paydown Yield | 0.04% |